Episode Overview In this episode, we had an insightful conversation with Alan White, CEO & Co-founder of Arriello, exploring global regulatory affairs, pharmacovigilance, quality, and compliance—and how the combination of technology and human expertise is reshaping the future of life sciences.

Alan shares his unconventional journey—from a commercial career spanning IT, lighting, and translation services into the pharmaceutical industry—and how his exposure to regulatory-driven services led to the founding of Arriello in 2008. He reflects on the early challenges of building credibility, navigating the post-2008 financial environment, and scaling Arriello from a small startup into a global organization supporting clients across more than 140 markets.

Key Topics Discussed The inspiration behind founding Arriello and its early growth journey Building trust and credibility as a new regulatory and compliance consultancy Arriello’s evolution from post-marketing support to clinical, safety, and strategic advisory services The realities of fragmented global regulatory systems—and why local expertise matters Common mistakes biotech companies make when planning global market entry The growing role of AI and automation—and why a human-in-the-loop approach remains critical Leadership, culture, and managing distributed global teams in a post-COVID world How technology and human expertise will shape the future of compliance